Addition of hyaluronic acid to the FIB‐4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study

Autor: Nicola N. Zammitt, Peter C. Hayes, Joanne R Morling, Jonathan A. Fallowfield, Rebecca M. Reynolds, Stela McLachlan, Indra Neil Guha, Sheila M. Grecian, Brian M. Frier, Mark W. J. Strachan, S Glancy, Rachel M. Williamson, Jacqueline F. Price

Publikováno v: Obesity Science & Practice, Vol 7, Iss 5, Pp 497-508 (2021)
Obesity Science & Practice

Background: Type 2 diabetes is associated with increased risk of progression to cirrhosis and hepatocellular carcinoma (HCC) in people with chronic liver diseases, particularly non-alcoholic fatty liver disease (NAFLD). However, the absolute risk of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74594c6724cdfaf3f1c36d2cb569e142
https://doi.org/10.1002/osp4.484

Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammation

Autor: Jackie F. Price, Mark W. J. Strachan, Sheila M. Grecian, Rachel Forster, Anniek J. Sluiman, Alistair L. Carr, Stela McLachlan

Publikováno v: Carr, A L, Sluiman, A, Grecian, S, Forster, R, McLachlan, S, Strachan, M & Price, J F 2020, ' Depression as a Risk Factor for Dementia in Older People with Type 2 Diabetes and the Mediating Effect of Inflammation ', Diabetologia . https://doi.org/10.1007/s00125-020-05301-6
Diabetologia

Aims/hypothesis We aimed to determine the association of depression with dementia risk in people with type 2 diabetes, and to explore the possible mediating role of inflammation in this relationship. Methods The Edinburgh Type 2 Diabetes Study is a p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2731443ffa6bc65ee96cdce3c9be2362
https://doi.org/10.1007/s00125-020-05301-6

Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh Type 2 Diabetes Study

Autor: Peter C. Hayes, Stela McLachlan, Patrick K. A. Kearns, Jackie F. Price, Mark W. J. Strachan, Jonathan A. Fallowfield, Joanne R Morling, Neil Guha, Sheila M. Grecian, Rachel M. Williamson, Brian M. Frier, Rebecca M. Reynolds, S Glancy, Nicola N. Zammitt

Publikováno v: Grecian, S, McLachlan, S, Fallowfield, J A, Kearns, P, Hayes, P C, Guha, I N, Morling, J, Glancy, S, Williamson, R M, Reynolds, R M, Frier, B, Zammitt, N N, Price, J F & Strachan, M 2020, ' Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh Type 2 Diabetes Study ', Liver International . https://doi.org/10.1111/liv.14590

BACKGROUND The incidence of cirrhosis and hepatocellular carcinoma (HCC) is increased in Type 2 diabetes, primarily secondary to non-alcoholic fatty liver disease (NAFLD). European guidelines recommend screening for NAFLD in Type 2 diabetes. American

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5db926f7af644504716ef89eaf227371
https://www.pure.ed.ac.uk/ws/files/155725606/Risk_scores_for_cirrhosisHCC_in_diabetes_for_liver_international_revised_2_unmarked_copy.docx

Adoption of the British Thyroid Association guidelines for the investigation of thyroid nodules: a district general hospital experience

Autor: Rachel M. Williamson, Sheila M. Grecian, Mark Strachan, Olive Herlihy, Luis Ferrando, Dilip Patel

Publikováno v: Endocrine Abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ace01ffadc4627637588fc30c681729
https://doi.org/10.1530/endoabs.50.p410